title: Trends in the use of intravenous recombinant tissue plasminogen activator from northwest India.
authors.forename: Jeyaraj D
authors.initials: JD
authors.lastname: Pandian
authors.forename: Ranjeet Singh
authors.initials: RS
authors.lastname: Bhullar
authors.forename: Parmdeep
authors.initials: P
authors.lastname: Kaur
authors.forename: Sudeepa
authors.initials: S
authors.lastname: Dhillon
authors.forename: Gagan
authors.initials: G
authors.lastname: Toor
authors.forename: Yashpal
authors.initials: Y
authors.lastname: Singh
mesh_terms: D002543:Cerebral Hemorrhage / Q000139:chemically induced; D015331:Cohort Studies; D004632:Emergency Medical Services / Q000706:statistics & numerical data; D005343:Fibrinolytic Agents / Q000008:administration & dosage*; D006801:Humans; D007194:India; D011446:Prospective Studies; D011994:Recombinant Proteins / Q000008:administration & dosage; D020521:Stroke / Q000188:drug therapy*; D013997:Time Factors; D010959:Tissue Plasminogen Activator / Q000008:administration & dosage*
chemical_list: D005343:Fibrinolytic Agents; D011994:Recombinant Proteins; D010959:Tissue Plasminogen Activator